Connolly Joan 4

Accession 0000929638-26-000479

CIK 0001980845other

View on SEC.gov Company Profile

Filed

Feb 2, 7:00 PM ET

Accepted

Feb 3, 4:07 PM ET

Size

5.1 KB

Accession

0000929638-26-000479

Research Summary

AI-generated summary of this filing

Updated Feb 3, 2026

enGene (ENGN) CTO Joan Connolly Receives 195,000-Share Option Award

What Happened
Joan Connolly, Chief Technology Officer of enGene Holdings, was granted a derivative award (an option) covering 195,000 shares on January 30, 2026. The reported acquisition price is $0.00, meaning no cash was paid at grant. This is a grant/award for compensation purposes rather than an open-market purchase or sale.

Key Details

Transaction date: 2026-01-30; Form 4 filed 2026-02-03 (timely filing).
Security: Derivative (option) for 195,000 shares; reported acquisition price $0.00.
Vesting: Option vests monthly in substantially equal amounts over 48 months, subject to continued service (per footnote).
Shares owned after transaction: Not reported in this filing.
Transaction code: A = Award/Grant.

Context
Option grants are common executive compensation and are intended to align management incentives with shareholder value over time. Because this is a vesting award (not an immediate purchase or sale), it does not reflect an immediate market buy/sell decision; value is realized only as options vest and — if exercised — shares are acquired.